Press release
Global Contraceptive Drugs Market is anticipated to grow at a CAGR of 4.32% by 2027 | DelveInsight Estimates
Contraceptive Drugs Market
DelveInsight's Contraceptive Drugs Market Insights and Forecast report provides the current and forecasted Contraceptive Drugs Market forecasts for next five years, upcoming innovation in individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Contraceptive Drugs Market.
To know more about the Contraceptive Drugs Market Report, click here: https://www.delveinsight.com/report-store/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some facts of the Contraceptive Drugs Market are:
• Global contraceptive drugs market was valued at USD 8.59 billion in 2021, growing at a CAGR of 4.32% during the forecast period from 2022 to 2027 to reach USD 11.04 billion by 2027.
• As per the data provided by the World Health Organization (2022), 4 million women living in low and middle-income countries have unintended pregnancies annually across the globe.
• The United Nation's Department of Economic and Social Affairs 2019 statistics mentioned that approximately 922 million women of reproductive age (or their partners) use contraception methods comprising various products of which contraceptive pills are one of the most common and reliable sources for avoiding unintended pregnancies.
• Some of the key market players operating in the contraceptive drugs market includes Abbvie Inc, BAYER AG, Viatris Inc, Gedeon Richter Plc., Agile Therapeutics, Evofem Biosciences, Inc., Amneal Pharmaceuticals LLC., Pfizer Inc, Hana, Maxwellia Ltd., Piramal Enterprises, Mankind Pharma, HLL Lifecare Limited, Theramex, Besins Healthcare, Marlborough Pharmaceuticals, Teva Pharmaceuticals USA, Inc, and others
Request for free sample to know more about the Contraceptive Drugs Market facts: https://www.delveinsight.com/report-store/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key market players operating in the contraceptive drugs market includes
• Abbvie Inc
• BAYER AG
• Viatris Inc
• Gedeon Richter Plc.
• Agile Therapeutics
• Evofem Biosciences, Inc.
• Amneal Pharmaceuticals LLC.
• Pfizer Inc
• Hana
• Maxwellia Ltd.
• Piramal Enterprises
• Mankind Pharma
• HLL Lifecare Limited
• Theramex
• Besins Healthcare
• Marlborough Pharmaceuticals
• Teva Pharmaceuticals USA, Inc
• And others
To know more about the Contraceptive Companies working in the Drug Market, click here: https://www.delveinsight.com/sample-request/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Recent Developmental Activities in Contraceptive Drugs Market:
• In May 2020, the US FDA approved Phexxi™ (lactic acid, citric acid and potassium bitartrate) vaginal gel for the prevention of pregnancy in females with reproductive potential.
• Bayer and Daré Bioscience entered into an exclusive license agreement for the US commercial rights to investigational hormone-free, monthly contraceptive Ovaprene® in January 2020. As per this agreement, Bayer may commercialize Daré's investigational contraceptive product, Ovaprene® in the United States once approved by the FDA.
• Gedeon Richter Plc. signed an asset purchase agreement with Janssen Pharmaceutica NV on December 2020, in respect of Janssen's Outside US Evra® transdermal contraceptive patch assets. The transaction amounted to approximately around USD 263.5 million.
Know more about the recent developments in Contraceptive Drugs Market by downloading the sample page, click here: https://www.delveinsight.com/report-store/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of Contraceptive Drugs Market Report:
• Study Period: 2019-2027
• Base Year: 2021
• Forecast Period: 2022-2027
• Contraceptive Drugs Market By Product Type (Oral Contraceptive Pills [Combination And Progestin-Only], Injectables, Topical Contraceptives [Gels & Jellies, Patches, And Creams])
• Contraceptive Drugs Market By Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, And Others)
• Contraceptive Drugs Market By geography ((North America, Europe, Asia-Pacific, and Rest of the World)
• Contraceptive Drugs Companies: Abbvie Inc, BAYER AG, Viatris Inc, Gedeon Richter Plc., Agile Therapeutics, Evofem Biosciences, Inc., Amneal Pharmaceuticals LLC., Pfizer Inc, Hana, Maxwellia Ltd., Piramal Enterprises, Mankind Pharma, HLL Lifecare Limited, Theramex, Besins Healthcare, Marlborough Pharmaceuticals, Teva Pharmaceuticals USA, Inc, and others
DelveInsight's Analysis: Global contraceptive drugs market was valued at USD 8.59 billion in 2021, growing at a CAGR of 4.32% during the forecast period from 2022 to 2027 to reach USD 11.04 billion by 2027.
Click here to know more about the Scope of the Contraceptive Drugs Market Report: https://www.delveinsight.com/report-store/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents:
1. Contraceptive Drugs Market Report Introduction
2. Contraceptive Drugs & Market Executive Summary
3. Regulatory Analysis
4. Contraceptive Drugs Market Key Factors Analysis
5. Contraceptive Drugs Market Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Contraceptive Drugs Market
7. Contraceptive Drugs Market Layout
8. Contraceptive Drugs Market Global Company Share Analysis; Key 3-5 Companies
9. Contraceptive Drugs Market Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us
Request for Detailed TOC: https://www.delveinsight.com/sample-request/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Contraceptive Drugs Market is anticipated to grow at a CAGR of 4.32% by 2027 | DelveInsight Estimates here
News-ID: 2685118 • Views: …
More Releases from DelveInsight Business Research
Diabetic Kidney Disease Treatment Market 2034: EMA, PDMA, FDA Approvals, Prevale …
(Albany, USA) DelveInsight's Diabetic Kidney Disease Market Insights report includes a comprehensive understanding of current treatment practices, diabetic kidney disease emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into 7MM [the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan].
Key Takeaways from the Diabetic Kidney Disease Market Report
• Diabetic Kidney Disease Market is anticipated to…
Hypercholesterolaemia Clinical Trials 2024: FDA Approvals, Medication, Pipeline …
(Albany, USA) As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in the Hypercholesterolaemia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Hypercholesterolaemia Pipeline Insight, 2024" report by DelveInsight provides a comprehensive analysis…
Motor Neuron Disease Clinical Trials 2024: FDA Approvals, Medication, Pipeline, …
(Albany, United States) According to DelveInsight's assessment, the global pipeline for Motor Neuron Disease includes over 180 key companies actively working on the development of more than 200 treatment therapies. DelveInsight's analysis covers clinical trials, therapies, mechanisms of action, routes of administration, and recent developments.
"Motor Neuron Disease Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Motor Neuron Disease…
Graves Disease Clinical Trials 2024: FDA Approvals, Mediction, Therapies, Treatm …
(Albany, United States) As per DelveInsight's assessment, globally, Graves Disease pipeline constitutes 8+ key companies continuously working towards developing 10+ Graves Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Graves Disease Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Graves Disease Market.
The Graves Disease Pipeline report embraces in-depth commercial…
More Releases for Contraceptive
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones…
Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,…
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones…
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede
As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the…
Global Contraceptives Drugs And Devices Market, By Product Type (Contraceptive D …
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects. The use of contraceptives can avoid…
Oral Contraceptive Pills Market: Snapshot
Teva Pharmaceutical is one of the leading companies in the combination oral contraceptive pills segment and is followed by Allergan (Actavis) plc. Local manufacturers such as Alkem, Taj Pharma, and Zydus Alidec on the other hand, held a majority of the market for ormeloxifene and mifepristone. Transparency Market Research has observed that almost all manufacturers offer combination oral contraceptive pills owing to the fact that they are more efficient, cost…
